Previous close | 35.30 |
Open | 38.71 |
Bid | 37.00 |
Ask | 40.45 |
Strike | 105.00 |
Expiry date | 2026-01-16 |
Day's range | 38.71 - 38.71 |
Contract range | N/A |
Volume | |
Open interest | 276 |
Earnings preview of key companies reporting next week and what to look out for.
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024. Number of
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.